MedPath

The Effect of Creatine on Muscle Loss

Not Applicable
Completed
Conditions
Muscle Loss
Interventions
Other: Placebo supplementation
Other: Creatine supplementation
Registration Number
NCT01894737
Lead Sponsor
Maastricht University Medical Center
Brief Summary

The primary aim of this study is to determine the effect of creatine supplementation on muscle mass loss during short-term immobilisation in healthy, young people.

Detailed Description

Seven days of one-legged knee immobilisation in young subjects with creatine or Placebo supplementation. A randomly selected leg is immobilized for seven days. Muscle mass and strength will be determined and muscle biopsies will be collected before and immediately after immobilisation. A week after the cast is removed we will assess any differences in recovery between intervention groups.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
30
Inclusion Criteria
  • Male
  • Aged from 18-35 years
  • 18.5 < BMI < 30 kg/m2
Exclusion Criteria
  • (Family) history of thrombosis
  • Smoking
  • Recent surgery
  • Performing regular resistance training more than once per week in the past year
  • Any back/leg/knee/shoulder complaints which may interfere with the use of crutches
  • Current systemic use of corticosteroids, growth hormone, testosterone, immunosuppressants or insulin
  • All co-morbidities interacting with mobility and muscle metabolism of the lower limbs (e.g. arthritis, spasticity/rigidity, all neurological disorders and paralysis)
  • Use of anti-coagulants
  • Pre-existing renal disease or those with a potential risk for renal dysfunction (diabetes, hypertension, reduced glomerular filtration rate)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
immobilisation and placeboPlacebo supplementationSeven days of one-legged knee immobilisation with placebo supplementation
immobilisation and creatineCreatine supplementationSeven days of one-legged knee immobilisation with creatine supplementation
Primary Outcome Measures
NameTimeMethod
change in quadriceps muscle cross-sectional area (CSA)Before and after 1 week of immobilisation, and after 1 week of recovery

immediately before and after 1 week of immobilisation, and after 1 week recovery, quadriceps CSA will be assessed

Secondary Outcome Measures
NameTimeMethod
change in muscle strengthbefore and after 1 week of immobilisation, and after 1 week of recovery

immediately before and after 1 week of immobilization, and after 1 week of natural recovery, one-repetition maximum (1RM) muscle strength will be assessed

change in muscle fiber type specific CSABefore and after 1 week of immobilisation, and after 1 week of recovery

immediately before and after 1 week of immobilization, and after 1 week of natural recovery

Trial Locations

Locations (1)

Maastricht University Medical Centre+

🇳🇱

Maastricht, Limburg, Netherlands

© Copyright 2025. All Rights Reserved by MedPath